CA2562738C - Soluble rubella e1 envelope antigens - Google Patents

Soluble rubella e1 envelope antigens Download PDF

Info

Publication number
CA2562738C
CA2562738C CA2562738A CA2562738A CA2562738C CA 2562738 C CA2562738 C CA 2562738C CA 2562738 A CA2562738 A CA 2562738A CA 2562738 A CA2562738 A CA 2562738A CA 2562738 C CA2562738 C CA 2562738C
Authority
CA
Canada
Prior art keywords
rubella
cys
antigen
amino acids
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2562738A
Other languages
English (en)
French (fr)
Other versions
CA2562738A1 (en
Inventor
Ralf Bollhagen
Alfred Engel
Elke Faatz
Peter Schaarschmidt
Christian Scholz
Barbara Upmeier
Toralf Zarnt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CA2562738A1 publication Critical patent/CA2562738A1/en
Application granted granted Critical
Publication of CA2562738C publication Critical patent/CA2562738C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2562738A 2005-10-26 2006-10-23 Soluble rubella e1 envelope antigens Active CA2562738C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05109993.5 2005-10-26
EP05109993 2005-10-26

Publications (2)

Publication Number Publication Date
CA2562738A1 CA2562738A1 (en) 2007-04-26
CA2562738C true CA2562738C (en) 2011-07-12

Family

ID=37965193

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2562738A Active CA2562738C (en) 2005-10-26 2006-10-23 Soluble rubella e1 envelope antigens

Country Status (6)

Country Link
US (1) US7604935B2 (enExample)
JP (1) JP4116054B2 (enExample)
AT (1) ATE491030T1 (enExample)
CA (1) CA2562738C (enExample)
DE (1) DE602006018694D1 (enExample)
ES (1) ES2356383T3 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4871960B2 (ja) * 2006-01-03 2012-02-08 エフ．ホフマン−ラ ロシュ アーゲー 優れたシャペロン活性およびフォールディング活性を有するキメラ融合タンパク質
EP2178896A1 (en) * 2007-07-31 2010-04-28 The Johns Hopkins University Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
CN101939330B (zh) * 2007-12-13 2014-06-04 霍夫曼-拉罗奇有限公司 新型风疹e1包膜蛋白变体及其在检测抗风疹抗体中的用途
AR086250A1 (es) * 2011-05-05 2013-11-27 Hoffmann La Roche Polipeptido de fusion presentador de una secuencia de aminoacidos y utilizacion del mismo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2095818B (en) 1981-03-27 1985-10-02 Exxon Research Engineering Co Staged adsorption/resorption heat pump
EP0299673A1 (en) 1987-07-08 1989-01-18 London Biotechnology Limited Rubella E1 glycoprotein antigens
JP2001501093A (ja) 1996-09-26 2001-01-30 メディカル リサーチ カウンシル シャペロン断片
DE19649390A1 (de) 1996-11-29 1998-06-04 Boehringer Mannheim Gmbh Antigenspezifischer IgG-Nachweis
ATE522603T1 (de) 2001-06-22 2011-09-15 Hoffmann La Roche Löslicher komplex, der retrovirale oberflächen- glykoproteine und fkpa oder slyd enthält

Also Published As

Publication number Publication date
ES2356383T3 (es) 2011-04-07
JP4116054B2 (ja) 2008-07-09
ATE491030T1 (de) 2010-12-15
CA2562738A1 (en) 2007-04-26
US7604935B2 (en) 2009-10-20
US20070154883A1 (en) 2007-07-05
DE602006018694D1 (de) 2011-01-20
JP2007117090A (ja) 2007-05-17

Similar Documents

Publication Publication Date Title
Baer et al. Specific RNA binding by amino‐terminal peptides of alfalfa mosaic virus coat protein.
US8551696B2 (en) Rubella E1 envelope protein variants and their use in detection of anti-rubella antibodies
CA2667177C (en) Slpa as a tool for recombinant protein and enzyme technology
AU717875B2 (en) HCV NS3 protein fragments having helicase activity and improved solubility
IE911129A1 (en) Hepatitis c virus protease
JP2968048B2 (ja) 表面プラズモン共鳴に基づく酵素アッセイ
CA2856187C (en) Soluble immunoreactive treponema pallidum tpn47 antigens
US10197559B2 (en) Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays
EP0638122B1 (en) Cdna sequence of dengue virus serotype 1 (singapore strain)
CN101351550A (zh) 具有卓越的伴侣和折叠活性的嵌合融合蛋白
EP1780282B1 (en) Recombinant expression of Rubella E1 envelope protein variants as chaperone fusion-proteins, and their use in the detection of anti-Rubella antibodies
US7604935B2 (en) Soluble rubella E1 envelope protein variants
CA2938712A1 (en) Soluble and immunoreactive variants of htlv capsid antigen p24
US20100152110A1 (en) Alternate reading frame polypeptides derived from hepatitis c and methods of their use
KR100605322B1 (ko) 씨형 간염 바이러스 항-코아 단백질 항체 진단에 유용한민감도 높은 항원성 에피토프
HK1148026B (en) Novel rubella e1 envelope protein variants and their use in the detection of antirubella antibodies
JP2001514006A (ja) モザイクタンパク質およびこれを作製するための制限エンドヌクレアーゼ補助連結方法
HK1138620B (en) Slpa as a tool for recombinant protein and enzyme technology
HK1229824A1 (en) Soluble and immunoreactive variants of htlv capsid antigen p24

Legal Events

Date Code Title Description
EEER Examination request
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 18TH ANNIV.) - STANDARD

Year of fee payment: 18

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240924

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240924

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240924

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 19TH ANNIV.) - STANDARD

Year of fee payment: 19

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250925

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250925